<html class="js" lang="en-gb"><head>
<meta charset="utf-8"/>
<meta content="IE=Edge,chrome=1" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width,initial-scale=1.0,maximum-scale=2.5,user-scalable=yes" name="viewport"/>
<meta content="Springer US" name="citation_publisher"/>
<meta content="Abuse of Gabapentin is Associated with Opioid Addiction" name="citation_title"/>
<meta content="10.1007/s11126-016-9421-7" name="citation_doi"/>
<meta content="en" name="citation_language"/>
<meta content="https://link.springer.com/article/10.1007/s11126-016-9421-7" name="citation_abstract_html_url"/>
<meta content="https://link.springer.com/article/10.1007/s11126-016-9421-7" name="citation_fulltext_html_url"/>
<meta content="https://link.springer.com/content/pdf/10.1007%2Fs11126-016-9421-7.pdf" name="citation_pdf_url"/>
<meta content="http://api.springer.com/metadata/pam?q=doi:10.1007/s11126-016-9421-7&amp;api_key=" name="citation_springer_api_url"/>
<meta content="763" name="citation_firstpage"/>
<meta content="767" name="citation_lastpage"/>
<meta content="Leo Bastiaens" name="citation_author"/>
<meta content="Renewal Treatment Inc." name="citation_author_institution"/>
<meta content="lbastiaens@renewalinc.com" name="citation_author_email"/>
<meta content="James Galus" name="citation_author"/>
<meta content="Renewal Treatment Inc." name="citation_author_institution"/>
<meta content="Cherise Mazur" name="citation_author"/>
<meta content="Renewal Treatment Inc." name="citation_author_institution"/>
<meta content="10.1007/s11126-016-9421-7" name="dc.identifier"/>
<meta content="telephone=no" name="format-detection"/>
<meta content="The objective of this study was to evaluate the extent of gabapentin misuse in a dually diagnosed correctional population, and to evaluate if this abuse is specific to the presence of an opioid use..." name="description"/>
<meta content="summary" name="twitter:card"/>
<meta content="Abuse of Gabapentin is Associated with Opioid Addiction" name="twitter:title"/>
<meta content="https://static-content.springer.com/cover/journal/11126/87/4.jpg" name="twitter:image"/>
<meta content="Content cover image" name="twitter:image:alt"/>
<meta content="SpringerLink" name="twitter:site"/>
<meta content="The objective of this study was to evaluate the extent of gabapentin misuse in a dually diagnosed correctional population, and to evaluate if this abuse is specific to the presence of an opioid use..." name="twitter:description"/>
<meta content="Psychiatric Quarterly" name="citation_journal_title"/>
<meta content="Psychiatr Q" name="citation_journal_abbrev"/>
<meta content="87" name="citation_volume"/>
<meta content="4" name="citation_issue"/>
<meta content="0033-2720" name="citation_issn"/>
<meta content="1573-6709" name="citation_issn"/>
<meta content="2016/02/18" name="citation_online_date"/>
<meta content="2016/12/01" name="citation_cover_date"/>
<meta content="Original Paper" name="citation_article_type"/>
<meta content="Abuse of Gabapentin is Associated with Opioid Addiction" property="og:title"/>
<meta content="Article" property="og:type"/>
<meta content="https://link.springer.com/article/10.1007/s11126-016-9421-7" property="og:url"/>
<meta content="https://static-content.springer.com/cover/journal/11126/87/4.jpg" property="og:image"/>
<meta content="SpringerLink" property="og:site_name"/>
<meta content="The objective of this study was to evaluate the extent of gabapentin misuse in a dually diagnosed correctional population, and to evaluate if this abuse is specific to the presence of an opioid use..." property="og:description"/>
<title>Abuse of Gabapentin is Associated with Opioid Addiction | SpringerLink</title>
<link href="https://link.springer.com/article/10.1007/s11126-016-9421-7" rel="canonical"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/favicon.ico" rel="shortcut icon"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/favicon.ico" rel="icon" sizes="16x16 32x32 48x48"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/favicon-48x48.png" rel="icon" sizes="48x48" type="image/png"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-iphone@3x.png" rel="apple-touch-icon"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/ic_launcher_hdpi.png" rel="apple-touch-icon" sizes="72x72"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-ipad.png" rel="apple-touch-icon" sizes="76x76"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-114x114.png" rel="apple-touch-icon" sizes="114x114"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-iphone@2x.png" rel="apple-touch-icon" sizes="120x120"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/ic_launcher_xxhdpi.png" rel="apple-touch-icon" sizes="144x144"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-ipad@2x.png" rel="apple-touch-icon" sizes="152x152"/>
<link href="https://link.springer.com/springerlink-static/2055516157/images/favicon/app-icon-iphone@3x.png" rel="apple-touch-icon" sizes="180x180"/>
<meta content="#ffffff" name="msapplication-TileColor"/>
<meta content="/springerlink-static/2055516157/images/favicon/ic_launcher_xxhdpi.png" name="msapplication-TileImage"/>
<link href="//fonts.gstatic.com" rel="dns-prefetch"/>
<link href="//fonts.googleapis.com" rel="dns-prefetch"/>
<link href="//google-analytics.com" rel="dns-prefetch"/>
<link href="//www.google-analytics.com" rel="dns-prefetch"/>
<link href="//www.googletagservices.com" rel="dns-prefetch"/>
<link href="//www.googletagmanager.com" rel="dns-prefetch"/>
<link href="//static-content.springer.com" rel="dns-prefetch"/>
<link href="https://link.springer.com/springerlink-static/2055516157/css/basic.css" media="screen" rel="stylesheet"/>
<link class="js-ctm" href="https://link.springer.com/springerlink-static/2055516157/css/styles.css" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)" rel="stylesheet"/>
<link href="https://link.springer.com/springerlink-static/2055516157/css/print.css" media="print" rel="stylesheet"/>
<script async="" src="https://www.google-analytics.com/analytics.js" type="text/javascript"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-WCF9Z9"></script><script type="text/javascript">
        window.Krux||((Krux=function(){Krux.q.push(arguments);}).q=[]);
        var dataLayer = [{
                'GA Key':"UA-26408784-1",
                'Features':["leaderboardadverts","eventtracker","trackingpixel"],
                'Event Category':"Article",
                'Open Access':"N",
                'Labs':"Y",
                'DOI':"10.1007/s11126-016-9421-7",
                'VG Wort Identifier':"pw-vgzm.415900-10.1007-s11126-016-9421-7",
                'hasAccess':"Y",
                'Full HTML':"Y",
                'Has Body':"Y",
                'Static Hash':"2055516157",
                'Has Preview':"N",
                'user':{"license":{"businessPartnerID":["3000081220","3000178775","3000215760","3000240761"],"businessPartnerIDString":"3000081220|3000178775|3000215760|3000240761"}},
                'content':{"serial":{"eissn":"1573-6709","pissn":"0033-2720"},"type":"Article","category":{"pmc":{"primarySubject":"Medicine & Public Health","primarySubjectCode":"H","secondarySubjects":{"1":"Psychiatry","2":"Public Health","3":"Sociology, general"},"secondarySubjectCodes":{"1":"H53003","2":"H27002","3":"X22000"}},"sucode":"Medicine"}},
                'Access Type':"subscription",
                'Page':"article",
                'Bpids':"3000081220, 3000178775, 3000215760, 3000240761",
                'Bpnames':"National University of Ireland Galway, James Hardiman Lib, IRIS - LNCS, IReL Consortium c/o The Library Maynooth University, 1255 IRIS Ireland",
                'SubjectCodes':"SCH, SCH53003, SCH27002, SCX22000",
                'session':{"authentication":{"loginStatus":"N"},"attributes":{"edition":"academic"}},
                'eventTrackerBaseUrl':"https://event-tracker.springernature.com",
                'Keywords':"Gabapentin abuse, Opioid addiction, Correctional population",
                'Country':"IE",
                'Journal Id':"11126",
                'Journal Title':"Psychiatric Quarterly",

                    'doi': "10.1007-s11126-016-9421-7",
                    'kwrd': ["Gabapentin_abuse","Opioid_addiction","Correctional_population"],
                    'pmc': ["H","H53003","H27002","X22000"],
                    'BPID': ["3000081220","3000178775","3000215760","3000240761"],
                    'ksg': Krux.segments,
                    'kuid': Krux.uid,

        }];
    </script>
<script src="https://link.springer.com/springerlink-static/2055516157/js/jquery-3.3.1.min.js" type="text/javascript"></script>
<script charset="UTF-8" src="https://cdn.cookielaw.org/consent/6b2ec9cd-5ace-4387-96d2-963e596401c6.js" type="text/javascript"></script><link href="https://optanon.blob.core.windows.net/skins/default_flat_bottom_two_button_white/v2/css/optanon.css" rel="stylesheet" type="text/css"/><style>#optanon ul#optanon-menu li { background-color: #F7FBFE !important }#optanon ul#optanon-menu li.menu-item-selected { background-color: #FFFFFF !important }#optanon #optanon-popup-wrapper .optanon-white-button-middle { background-color: #3365A4 !important }.optanon-alert-box-wrapper .optanon-alert-box-button-middle { background-color: #3365A4 !important; border-color: #3365A4 !important; }#optanon #optanon-popup-wrapper .optanon-white-button-middle a { color: #ffffff !important }.optanon-alert-box-wrapper .optanon-alert-box-button-middle a { color: #ffffff !important }#optanon #optanon-popup-bottom { background-color: #F7FBFE !important }#optanon.modern #optanon-popup-top, #optanon.modern #optanon-popup-body-left-shading { background-color: #F7FBFE !important }.optanon-alert-box-wrapper { background-color:#F7FBFE !important }.optanon-alert-box-wrapper .optanon-alert-box-bg p { color:#333333 !important }</style>
<script type="text/javascript">
    function OptanonWrapper() {
        dataLayer.push({
            'event' : 'onetrustActive'
        });
    }
</script>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
                new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
            'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-WCF9Z9');</script>
</head>
<body><button aria-hidden="true" class="js-focus-catcher u-screenreader-only" href="javascript:;" tabindex="-1" title="focus catcher"></button><div aria-hidden="true" class="u-composite-layer popup-base-theme" id="popup-references" style="top:-60px;left:-60px;visibility:hidden;opacity:0;"><svg class="popup-arrow" height="18.4" viewbox="0 0 33.7 18.4" width="33.7" xmlns="http://www.w3.org/2000/svg"><path class="fill" d="M1.4 18.4h30.9l-15.5-16.9z" fill="#F7FBFE"></path><path class="stroke" d="M0 18.4h1.4l15.4-16.9 15.5 16.9h1.4l-16.9-18.4z" fill="#98BED7"></path></svg><div class="popup-arrow popup-arrow-shadow icon--popup-arrow-shadow"></div><div class="popup__references"><div class="popup-base-theme__inner" data-component="SpringerLink-Popup-inner" tabindex="-1"></div></div><button class="popup-close" data-component="SpringerLink-Popup-close" tabindex="-1"><img alt="Close" src="data:image/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2214%22%20height%3D%2214%22%3E%3Cpath%20fill%3D%22%23666%22%20d%3D%22M1.706.292A.996.996%200%200%200%20.294.294a1.002%201.002%200%200%200-.002%201.412L5.527%206.94.292%2012.177a.996.996%200%200%200%20.002%201.412c.39.39%201.026.385%201.412%200L6.94%208.354l5.236%205.235a.998.998%200%200%200%201.414-1.413L8.355%206.94l5.235-5.234a.996.996%200%200%200-.002-1.412%201.002%201.002%200%200%200-1.412-.002L6.94%205.527%201.707.292z%22%2F%3E%3C%2Fsvg%3E"/></button></div><div aria-hidden="true" class="u-composite-layer popup-search-theme" id="popup-search" style="top:-60px;left:-60px;visibility:hidden;opacity:0;"><svg class="popup-arrow" height="18.4" viewbox="0 0 33.7 18.4" width="33.7" xmlns="http://www.w3.org/2000/svg"><path class="fill" d="M1.4 18.4h30.9l-15.5-16.9z" fill="#F7FBFE"></path><path class="stroke" d="M0 18.4h1.4l15.4-16.9 15.5 16.9h1.4l-16.9-18.4z" fill="#98BED7"></path></svg><div class="popup-arrow popup-arrow-shadow icon--popup-arrow-shadow"></div><div class="popup__search"><div class="popup-base-theme__inner" data-component="SpringerLink-Popup-inner" tabindex="-1"></div></div><button class="popup-close" data-component="SpringerLink-Popup-close" tabindex="-1"><img alt="Close" src="data:image/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2214%22%20height%3D%2214%22%3E%3Cpath%20fill%3D%22%23666%22%20d%3D%22M1.706.292A.996.996%200%200%200%20.294.294a1.002%201.002%200%200%200-.002%201.412L5.527%206.94.292%2012.177a.996.996%200%200%200%20.002%201.412c.39.39%201.026.385%201.412%200L6.94%208.354l5.236%205.235a.998.998%200%200%200%201.414-1.413L8.355%206.94l5.235-5.234a.996.996%200%200%200-.002-1.412%201.002%201.002%200%200%200-1.412-.002L6.94%205.527%201.707.292z%22%2F%3E%3C%2Fsvg%3E"/></button></div>
<noscript><iframe height="0" src="//www.googletagmanager.com/ns.html?id=GTM-WCF9Z9" style="display:none;visibility:hidden" width="0"></iframe></noscript>
<div class="skip-to">
<a class="skip-to__link pseudo-focus" href="https://link.springer.com/#main-content">Skip to main content</a>
<a class="skip-to__link skip-to__link--contents pseudo-focus" href="https://link.springer.com/#article-contents">Skip to sections</a>
</div>
<div class="page-wrapper">
<noscript>
<div class="nojs-banner u-interface">
<p>This service is more advanced with JavaScript available, learn more at <a href="http://activatejavascript.org" rel="noopener" target="_blank">http://activatejavascript.org</a>
</p>
</div>
</noscript>
<div class="leaderboard u-hide" data-component="SpringerLink.GoogleAds" data-namespace="leaderboard" id="leaderboard">
<div class="leaderboard__wrapper">
<p class="leaderboard__label">Advertisement</p>
<button class="leaderboard__hide" data-track="click" data-track-action="Hide advertisement" data-track-label="" title="Hide this advertisement">Hide</button>
<div class="leaderboard__ad u-pt-24" id="doubleclick-leaderboard-ad"></div>
</div>
</div>
<header class="header u-interface" id="header">
<div class="header__content">
<div class="header__menu-container">
<a class="site-logo" href="https://link.springer.com/" id="logo" title="Go to homepage">
<div class="u-screenreader-only">SpringerLink</div>
<svg aria-hidden="true" class="site-logo__springer" focusable="false" height="30" role="img" width="148">
<image alt="" height="30" src="/springerlink-static/2055516157/images/png/springerlink.png" width="148" xlink:href="/springerlink-static/2055516157/images/svg/springerlink.svg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</svg>
</a>
<nav class="u-inline-block" id="search-container">
<div class="search">
<div class="search__content">
<form action="/search" class="u-form-single-input" method="get" role="search">
<label for="search-springerlink">Search SpringerLink</label>
<div class="u-relative">
<input autocomplete="off" id="search-springerlink" name="query" type="text" value=""/>
<input class="u-hide-text" title="Submit" type="submit" value="Submit"/>
<svg aria-hidden="true" class="u-vertical-align-absolute" focusable="false" height="13" role="presentation" version="1.1" viewbox="222 151 13 13" width="13" xmlns="http://www.w3.org/2000/svg">
<path d="M227 159C228.7 159 230 157.7 230 156 230 154.3 228.7 153 227 153 225.3 153 224 154.3 224 156 224 157.7 225.3 159 227 159L227 159 227 159 227 159ZM230 160.1L231.1 159 233.9 161.7C234.2 162.1 234.2 162.6 233.9 162.9 233.6 163.2 233.1 163.2 232.7 162.9L230 160.1 230 160.1 230 160.1 230 160.1ZM227 161L227 161C224.2 161 222 158.8 222 156 222 153.2 224.2 151 227 151 229.8 151 232 153.2 232 156 232 158.8 229.8 161 227 161L227 161 227 161 227 161 227 161Z" fill-rule="evenodd" stroke="none"></path>
</svg>
</div>
</form>
</div>
</div>
</nav>
<nav class="nav-container u-interface">
<div class="global-nav__wrapper">
<div class="search-button">
<a aria-controls="popup-search" aria-expanded="false" class="search-button__label" href="https://link.springer.com/#search-container" role="button">
<span class="search-button__title">Search</span><svg aria-hidden="true" focusable="false" height="12" role="presentation" version="1.1" viewbox="222 151 12 12" width="12" xmlns="http://www.w3.org/2000/svg">
<path d="M227 159C228.7 159 230 157.7 230 156 230 154.3 228.7 153 227 153 225.3 153 224 154.3 224 156 224 157.7 225.3 159 227 159L227 159 227 159 227 159ZM230 160.1L231.1 159 233.9 161.7C234.2 162.1 234.2 162.6 233.9 162.9 233.6 163.2 233.1 163.2 232.7 162.9L230 160.1 230 160.1 230 160.1 230 160.1ZM227 161L227 161C224.2 161 222 158.8 222 156 222 153.2 224.2 151 227 151 229.8 151 232 153.2 232 156 232 158.8 229.8 161 227 161L227 161 227 161 227 161 227 161Z" fill-rule="evenodd" stroke="none"></path>
</svg>
</a>
</div>
<ul class="global-nav" data-component="SV.Menu" data-text="Menu" data-title="Navigation menu">
<li>
<a href="https://link.springer.com/">
<span class="u-overflow-ellipsis">Home</span>
</a>
</li>
<li class="global-nav__logged-out">
<a class="test-login-link" href="//link.springer.com/signup-login?previousUrl=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs11126-016-9421-7">
<span class="u-overflow-ellipsis">Log in</span>
</a>
</li>
</ul><div aria-label="button with dropdown options" class="main-menu u-composite-layer c-button-dropdown c-button-dropdown--ghost" data-component="SV.Dropdown" data-namespace="Menu" style=""><button aria-controls="Dropdown-Menu-dropdown" aria-expanded="false" class="c-button-dropdown__button" data-role="button-dropdown__control" id="button-Dropdown-Menu-dropdown" title="Navigation menu" type="button"><span class="u-overflow-ellipsis c-button-dropdown__button-title">Menu</span><span class="c-button-dropdown__icon"></span></button><div aria-hidden="true" aria-label="dropdown" class="u-composite-layer c-button-dropdown__container" id="Dropdown-Menu-dropdown"><ul class="main-menu__content" data-role="button-dropdown__content"><li>
<a href="https://link.springer.com/">
<span class="u-overflow-ellipsis">Home</span>
</a>
</li><li class="global-nav__logged-out">
<a class="test-login-link" href="//link.springer.com/signup-login?previousUrl=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs11126-016-9421-7">
<span class="u-overflow-ellipsis">Log in</span>
</a>
</li></ul></div></div>
</div>
</nav>
</div>
</div>
</header>
<main class="main-wrapper" id="main-content" tabindex="-1">
<div class="main-container uptodate-recommendations-off">
<aside class="main-sidebar-left">
<div class="main-sidebar-left__content">
<div class="cover-image test-cover" itemscope="">
<a class="test-cover-link" href="https://link.springer.com/journal/11126">
<span class="u-screenreader-only">Psychiatric Quarterly</span>
<img alt="" class="test-cover-image" itemprop="image" src="https://media.springernature.com/w306/springer-static/cover/journal/11126/87/4.jpg"/>
</a>
</div>
</div>
</aside>
<div class="main-body" data-role="NavigationContainer">
<div class="cta-button-container cta-button-container--top cta-button-container--stacked u-mb-16 u-hide-two-col">
<div>
<a class="c-button c-button--blue c-button__icon-right" data-track="click" data-track-action="Pdf download" data-track-label="" href="https://link.springer.com/content/pdf/10.1007%2Fs11126-016-9421-7.pdf" rel="noopener" target="_blank" title="Download this article in PDF format">
<svg height="24" version="1.1" viewbox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd" stroke="none" stroke-width="1"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"></path></g></g></g></svg>
<span class="hide-text-small">Download</span>
<span>PDF</span>
</a>
</div>
</div>
<article class="main-body__content">
<div class="FulltextWrapper" xmlns="http://www.w3.org/1999/xhtml"><div class="ArticleHeader main-context"><div class="enumeration" id="enumeration"><p><a data-track="click" data-track-action="Journal title" data-track-label="" href="https://link.springer.com/journal/11126" title="Psychiatric Quarterly"><span class="JournalTitle">Psychiatric Quarterly</span></a></p><p class="icon--meta-keyline"><span class="ArticleCitation_Year"><time datetime="2016-12">December 2016</time>, </span><span class="ArticleCitation_Volume">Volume 87, </span><a class="ArticleCitation_Issue" data-track="click" data-track-action="Article issue" data-track-label="" href="https://link.springer.com/journal/11126/87/4/page/1">Issue 4</a>,
                       <span class="ArticleCitation_Pages"> pp 763–767</span><span class="u-inline-block u-ml-4"> | <a data-track="click" data-track-action="Cite as link" data-track-label="Enumeration section" href="https://link.springer.com/#citeas">Cite as</a></span></p></div><div class="MainTitleSection"><h1 class="ArticleTitle" lang="en">Abuse of Gabapentin is Associated with Opioid Addiction</h1></div><div class="authors u-clearfix authors--enhanced" data-component="SpringerLink.Authors"><ul class="u-interface u-inline-list authors__title" data-role="AuthorsNavigation"><li><a class="selected" data-track="click" data-track-action="Authors tab" data-track-label="" href="https://link.springer.com/#authors">Authors</a></li><li><a data-track="click" data-track-action="Authors and affiliations tab" data-track-label="" href="https://link.springer.com/#authorsandaffiliations">Authors and affiliations</a></li></ul><span class="marker" style="width: 160px;"></span><div class="authors__list" data-role="AuthorsList" id="authors" tabindex="-1"><ul class="test-contributor-names"><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors__name" itemprop="name">Leo Bastiaens</span><span class="author-information"><span class="authors__contact"><a data-track="click" data-track-action="Email author" data-track-label="" href="https://link.springer.com/article/10.1007/s11126-016-9421-7/mailto:lbastiaens@renewalinc.com" itemprop="email" title="lbastiaens@renewalinc.com"><img alt="Email author" height="24" src="https://link.springer.com/springerlink-static/images/svg/email.svg" width="24"/></a></span></span></li><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors__name" itemprop="name">James Galus</span></li><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors__name" itemprop="name">Cherise Mazur</span></li></ul></div><div class="authors__affiliations" id="authorsandaffiliations" tabindex="-1"><div class="authors-affiliations u-interface"><ul class="test-contributor-names"><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors-affiliations__name" itemprop="name">Leo Bastiaens</span><ul class="authors-affiliations__indexes u-inline-list" data-role="AuthorsIndexes"><li data-affiliation="affiliation-1">1</li></ul><span class="author-information"><span class="author-information__contact u-icon-before"><a data-track="click" data-track-action="Email author" data-track-label="" href="https://link.springer.com/article/10.1007/s11126-016-9421-7/mailto:lbastiaens@renewalinc.com" itemprop="email" tabindex="-1" title="lbastiaens@renewalinc.com">Email author</a></span></span></li><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors-affiliations__name" itemprop="name">James Galus</span><ul class="authors-affiliations__indexes u-inline-list" data-role="AuthorsIndexes"><li data-affiliation="affiliation-1">1</li></ul></li><li class="u-mb-2 u-pt-4 u-pb-4" itemscope="" itemtype="http://schema.org/Person"><span class="authors-affiliations__name" itemprop="name">Cherise Mazur</span><ul class="authors-affiliations__indexes u-inline-list" data-role="AuthorsIndexes"><li data-affiliation="affiliation-1">1</li></ul></li></ul><ol class="test-affiliations"><li class="affiliation" data-affiliation-highlight="affiliation-1" data-test="affiliation-1" itemscope="" itemtype="http://schema.org/Organization"><span class="affiliation__count">1.</span><span class="affiliation__item"><span class="affiliation__name" itemprop="name">Renewal Treatment Inc.</span><span class="affiliation__address" itemprop="address" itemscope="" itemtype="http://schema.org/PostalAddress"><span class="affiliation__city" itemprop="addressRegion">Pittsburgh</span><span class="affiliation__country" itemprop="addressCountry">USA</span></span></span></li></ol></div></div></div><div class="main-context__container" data-component="SpringerLink.ArticleMetrics"><div class="main-context__column"><span><span class="test-render-category">Original Paper</span></span><div class="article-dates"><span class="article-dates__label">First Online: </span><span class="article-dates__first-online"><time datetime="2016-02-18">18 February 2016</time></span></div></div><div class="main-context__column"> <ul class="article-metrics u-sansSerif" id="book-metrics">
<li class="article-metrics__item">
<a class="article-metrics__link gtm-socialmediamentions-count" href="http://www.altmetric.com/details.php?citation_id=5982905&amp;domain=link.springer.com" id="socialmediamentions-link" rel="noopener" target="_blank" title="Visit Altmetric for full social mention details">
<span class="test-metric-count c-button-circle gtm-socialmediamentions-count" id="socialmediamentions-count-number">22</span>
<span class="test-metric-name article-metrics__label gtm-socialmediamentions-count">Shares</span>
</a>
</li>
<li class="article-metrics__item">
<span class="article-metrics__views">1.5k</span>
<span class="article-metrics__label">Downloads</span>
</li>
<li class="article-metrics__item">
<a class="article-metrics__link gtm-citations-count" href="https://citations.springer.com/item?doi=10.1007/s11126-016-9421-7" id="citations-link" rel="noopener" target="_blank" title="Visit Springer Citations for full citation details">
<span class="test-metric-count c-button-circle gtm-citations-count" id="citations-count-number">21</span>
<span class="test-metric-name article-metrics__label gtm-citations-count">Citations</span>
</a>
</li>
</ul>
</div></div></div><section class="Abstract" id="Abs1" lang="en" tabindex="-1"><h2 class="Heading">Abstract</h2><p class="Para" id="Par4">The objective of this study was to evaluate the extent of gabapentin misuse in a dually diagnosed correctional population, and to evaluate if this abuse is specific to the presence of an opioid use disorder (OUD). Two-hundred and fifty former inmates, living in a correctional community center, who were referred for a psychiatric evaluation, were asked, through a brief written questionnaire, whether or not they used the following drugs for non-medical use in the past: opiates, gabapentin, buproprion, quetiapine, and fluoxetine. The average age of this population was 37.2 ± 12.1 years (n = 250). Sixty-four percent were male, 72 % were white, 27 % were black, and 1 % was Hispanic. All patients had substance use disorders, the large majority (72 %) to more than one substance. Fifty-eight percent had an opioid use disorder, again mostly in combination with other drugs and/or alcohol. Depressive disorders and attention deficit hyperactivity disorder were the most common psychiatric conditions. Sixty-two percent of patients reported prescription drug misuse of any kind. As expected, a high percent (55 %) reported opiate misuse. No patient reported fluoxetine misuse. Sixteen percent reported having misused gabapentin in the past. Of patients with an opioid use disorder (OUD: n = 145), 26 % endorsed gabapentin abuse while only 4 % of patients without an OUD (n = 105) endorsed the non-medical use of gabapentin. This difference was highly statistically significant (Chi square χ<sup>2</sup> = 21.6, p &lt; 0.0001). A growing concern about gabapentin misuse was supported in this study: 26 percent of opiate addicted patients reported illegally obtaining, overusing, or malingering problems to obtain gabapentin. This study highlights the fact that gabapentin abuse appears specific to an opioid addicted population.</p></section><div class="KeywordGroup" lang="en"><h2 class="Heading">Keywords</h2><span class="Keyword">Gabapentin abuse </span><span class="Keyword">Opioid addiction </span><span class="Keyword">Correctional population </span></div><div class="article-actions--inline" data-component="article-actions--inline" id="article-actions--inline"><div aria-label="button with dropdown options" class="citations u-interface c-button-dropdown" data-component="SV.Dropdown" data-namespace="citations--inline">
<button aria-controls="Dropdown-citations--inline-dropdown" aria-expanded="false" class="c-button-dropdown__button" data-role="button-dropdown__control" id="button-Dropdown-citations--inline-dropdown" type="button"><span class="u-overflow-ellipsis c-button-dropdown__button-title">
<span>Cite</span>
<span class="hide-text-small">article</span>
</span><span class="c-button-dropdown__icon"></span></button>
<div aria-hidden="true" aria-label="dropdown" class="u-composite-layer c-button-dropdown__container" id="Dropdown-citations--inline-dropdown"><ul class="citations__content" data-role="button-dropdown__content">
<li>
<a data-track="click" data-track-action="Cite as link" data-track-label="Cite dropdown" href="https://link.springer.com/#citeas">How to cite?</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="RIS" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=refman&amp;flavour=citation" title="Download this article's citation as a .RIS file">
<span class="citations__extension" data-gtmlabel="RIS">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .RIS
                </span>
<span class="citations__types">
<span>
                            Papers
                        </span>
<span>
                            Reference Manager
                        </span>
<span>
                            RefWorks
                        </span>
<span>
                            Zotero
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="ENW" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=endnote&amp;flavour=citation" title="Download this article's citation as a .ENW file">
<span class="citations__extension" data-gtmlabel="ENW">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .ENW
                </span>
<span class="citations__types">
<span>
                            EndNote
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="BIB" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=bibtex&amp;flavour=citation" title="Download this article's citation as a .BIB file">
<span class="citations__extension" data-gtmlabel="BIB">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .BIB
                </span>
<span class="citations__types">
<span>
                            BibTeX
                        </span>
<span>
                            JabRef
                        </span>
<span>
                            Mendeley
                        </span>
</span>
</a>
</li>
</ul></div>
</div></div><div id="body"><section class="Section1 RenderAsSection1 SectionTypeIntroduction" id="Sec1" tabindex="-1"><h2 class="Heading">Introduction</h2><div class="content"><p class="Para" id="Par5">“Prescription drug abuse is the use of a medication without a prescription, in a way other than as prescribed, or for the experience or feelings elicited”: in the United States, the abuse of prescription medications has been declared a public health problem [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR1" role="button" title="View reference">1</a></span>]. Most commonly, opioids have been implicated, although other DEA scheduled medications are misused as well, such as benzodiazepines and stimulants [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR2" role="button" title="View reference">2</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR3" role="button" title="View reference">3</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR4" role="button" title="View reference">4</a></span>].</p><p class="Para" id="Par6">Many factors may be involved in the perpetuation of this phenomenon. All of the abused medications are mind altering, especially when used in higher doses or delivered in different ways from medically indicated administrations. They are clinically indicated for conditions for which no objective measures exist, such as pain, anxiety, or attention problems. The absence of objective parameters for the severity of these conditions make it easy to obtain higher doses of prescribed medications, simply by reporting poor effectiveness, or by reporting symptoms that do not exist. Health care factors, such as overreliance on procedures and pills, societal factors with an emphasis on quick and easy ways of doing things, and physician factors with indiscriminate prescribing of medications with an addiction potential are among other reasons for this problem.</p><p class="Para" id="Par7">A growing concern is the misuse and abuse of non-DEA scheduled medications, medications that are deemed not to have an addictive potential. Several papers have described abuse of gabapentin, quetiapine, and buproprion in recent years [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR5" role="button" title="View reference">5</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR6" role="button" title="View reference">6</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR7" role="button" title="View reference">7</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR8" role="button" title="View reference">8</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR9" role="button" title="View reference">9</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR10" role="button" title="View reference">10</a></span>]. While these medications have specific FDA indications, they are often prescribed off label, for example, gabapentin for anxiety, buproprion for ADHD, and quetiapine for sleep. This off label prescribing tremendously increases the patient population exposed to these drugs. Also, patients with anxiety, insomnia or ADHD may have addiction co-morbidities, increasing the potential for abuse.</p><p class="Para" id="Par8">The true extent of abuse of non-scheduled drugs is unknown. Certain populations are clearly at higher risk: chronic pain patients, psychiatric patients and patients with addiction problems. Dual diagnosis, psychiatric and addiction, patients with a criminal background may be at highest risk because of the combination of recurrent recklessness, access to different substances in a drug-infested milieu, addiction to illicit drugs with cycles of intoxication and withdrawal, and mental health problems of depression and anxiety.</p><p class="Para" id="Par9">This study estimated the extent of gabapentin misuse in a correctional community center’s (CCC) population of dually diagnosed patients. Because of clinical experience and case reports, it was hypothesized that gabapentin abuse would be substantial, estimated at ten or more percent of the population. It was further hypothesized that this abuse would be specifically associated with opioid addiction. These hypotheses were based on recent studies [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR11" role="button" title="View reference">11</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR12" role="button" title="View reference">12</a></span>]. However, these studies did not investigate whether or not the association with an opioid use disorder is specific. The misuse of gabapentin in cocaine addiction has been reported as well [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR7" role="button" title="View reference">7</a></span>].</p><p class="Para" id="Par10">As a matter of exploration, quetiapine and buproprion were added to the study design because data from correctional institutions indicate abuse of these substances as well [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR8" role="button" title="View reference">8</a></span>].</p></div></section><section class="Section1 RenderAsSection1 SectionTypeMaterialsAndMethods" id="Sec2" tabindex="-1"><h2 class="Heading">Method</h2><div class="content"><p class="Para" id="Par11">The community correctional center’s treatment program provides integrated treatment for dually diagnosed, mental health and addiction, residents. A comprehensive intake process includes review of prison records, a drug and alcohol evaluation, and a psychiatric assessment. As part of this intake process, patients filled out a questionnaire about prescription drug abuse. The questionnaire first explained what was meant by prescription drug abuse (not having a prescription and obtaining the drug elsewhere; having a prescription but using too much; obtaining a prescription to use the drug for other than medical reasons). The questionnaire then asked which drugs had been used for non-medical reasons in the past: opiates, gabapentin (Neurontin), fluoxetine (Prozac), buproprion (Wellbutrin), and quetiapine (Seroquel). Opiates and fluoxetine were added to obtain some measure of validity, expecting opiates to be strongly endorsed and fluoxetine not to be endorsed. All patients signed informed consent for the assessments.</p></div></section><section class="Section1 RenderAsSection1 SectionTypeResults" id="Sec3" tabindex="-1"><h2 class="Heading">Results</h2><div class="content"><p class="Para" id="Par12">Two hundred and fifty patients completed the questionnaire. Three patients did not. The average age was 37.2 ± 12.1 years (n = 250). Sixty-four percent were male, 72 % were white, 27 % were black, and 1 % was Hispanic.</p><p class="Para" id="Par13">All patients had substance use disorders, the large majority (72 %) to more than one substance. Fifty-eight percent had an opioid use disorder, again mostly in combination with other drugs and/or alcohol.</p><p class="Para" id="Par14">Depressive disorders (25 %) and attention deficit hyperactivity disorder (25 %) were the most common psychiatric conditions necessitating treatment, followed by adjustment disorders (22 %), anxiety disorders (18 %), post traumatic stress disorder (11 %), bipolar disorder (8 %), and schizophrenia (3 %). Many patients were identified in the record as having antisocial personality disorder, but personality disorders were not systematically evaluated in this study.</p><p class="Para" id="Par15">Several indices of severity of psychiatric and addiction problems were present: 66 % had past inpatient addiction treatment, 48 % had past psychiatric hospitalizations, and 25 % had hepatitis C infection.</p><p class="Para" id="Par16">One hundred and fifty six patients (62 %) endorsed the non-medical use of any of the five listed medications: opiates (n = 138; 55 %), gabapentin (n = 41; 16 %), quetiapine (n = 21; 8 %), buproprion (n = 15; 6 %), fluoxetine (n = 0; 0 %).</p><p class="Para" id="Par17">Of patients with an opioid use disorder (OUD: n = 145), 37 endorsed gabapentin abuse (26 %) while only 4 patients without an OUD (n = 105) endorsed the non-medical use of gabapentin (4 %). This difference was highly statistically significant (Chi square X<sup>2</sup> = 21.6, p &lt; 0.0001). Only one of 30 patients (3 %) with a cocaine use disorder not co-morbid with an opioid use disorder reported abusing gabapentin.</p><p class="Para" id="Par18">Only 14 patients (6 %) abused quetiapine or buproprion in isolation from gabapentin.</p></div></section><section class="Section1 RenderAsSection1 SectionTypeDiscussion" id="Sec4" tabindex="-1"><h2 class="Heading">Discussion</h2><div class="content"><p class="Para" id="Par19">The results of this study need to be put in the context of its limitations. The main limitation is the fact that the results are entirely dependent on the patients’ self report. Patients with an antisocial and addiction background cannot be assumed to be truthful, as denial and manipulation are many times part of their life style. Because of this, two medications were used as validators: opiates, because they are well-known to be abused, and fluoxetine, which is not recognized as a misused medication. Fifty-five percent of the patient population indicated opiate abuse and zero percent indicated fluoxetine abuse, giving face validity to the results of the self report assessment. Nevertheless, an underreporting of abuse of gabapentin, quetiapine and buproprion is possible.</p><p class="Para" id="Par20">Another limitation is the patient population: correctional dually diagnosed individuals. This population may be at highest risk for abuse of any substance, so results cannot be generalized to other populations. The results were obtained cross-sectionally and no corroborating information was available.</p><p class="Para" id="Par21">The self-reported prescription drug abuse was extensive in this population. Almost two thirds of the patients reported using any of the five listed medications in a manner not prescribed to them.</p><p class="Para" id="Par22">The focus of this study was gabapentin, a non-scheduled medication by the DEA. This medication was approved in 1993 for seizures and post-herpetic neuralgia, without an evaluation of the dependence and abuse potential in human subjects. Additional studies examined the effectiveness of this medication in withdrawal syndromes [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR13" role="button" title="View reference">13</a></span>], bipolar disorder [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR14" role="button" title="View reference">14</a></span>], anxiety disorders [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR15" role="button" title="View reference">15</a></span>, <span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR16" role="button" title="View reference">16</a></span>], and insomnia [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR17" role="button" title="View reference">17</a></span>], among others. The findings were mixed and even though no other indications were added by the FDA, the benign tolerability profile may have contributed to off label prescribing, which has been extensive in the past 20 years.</p><p class="Para" id="Par23">Sixteen percent in this dual diagnosis population reported misusing gabapentin. This abuse was highly related to having an opioid use disorder: about one in four patients with an OUD endorsed using gabapentin in a non-medical manner. This number is very similar to the studies by Wilens [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR11" role="button" title="View reference">11</a></span>] and Baird [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR12" role="button" title="View reference">12</a></span>]: in both studies, 22 % of patients reported abuse of gabapentin. The new finding in this study is the fact that gabapentin abuse almost exclusively happened in an opioid addicted population.</p><p class="Para" id="Par24">The reasons for this association are unclear. The study by Baird highlighted the potentiation of the opiate high with gabapentin [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR12" role="button" title="View reference">12</a></span>]. Another possibility is the relief of anxiety symptoms associated with opioid withdrawal. A third possibility is the substitution of opioids with gabapentin. Animal data are consistent with this hypothesis [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR18" role="button" title="View reference">18</a></span>]: gabapentin appears to increase endogenous opioid peptide levels in the amygdala, a nucleus within the addiction circuitry in the brain [<span class="CitationRef"><a aria-controls="popup-references" aria-expanded="false" href="https://link.springer.com/#CR19" role="button" title="View reference">19</a></span>].</p><p class="Para" id="Par25">
In summary, this study confirmed previous findings of a substantial percentage of addiction patients misusing gabapentin, but specified that this misuse is related to the existence of an opioid addiction. It behooves physicians to incorporate these findings when considering off label prescribing of gabapentin.</p></div></section></div><section class="Section1 RenderAsSection1" id="Notes"><h2 class="Heading">Notes</h2><div class="content"><section><h3 class="Heading">Compliance with Ethical Standards</h3><div class="FormalPara FormalParaRenderingStyle1" id="FPar4"><h3 class="u-regular"><span class="Heading">Conflict of interest</span></h3><p class="Para" id="Par26">Leo Bastiaens, James Galus and Cherise Mazur declare that they have no conflict of interest.</p></div><div class="FormalPara FormalParaRenderingStyle1" id="FPar5"><h3 class="u-regular"><span class="Heading">Ethical approval</span></h3><p class="Para" id="Par27">All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p></div><div class="FormalPara FormalParaRenderingStyle1" id="FPar6"><h3 class="u-regular"><span class="Heading">Informed consent</span></h3><p class="Para" id="Par28">Informed consent was obtained from all individual participants included in the study.</p></div></section></div></section><section class="Section1 RenderAsSection1" id="Bib1" tabindex="-1"><h2 class="Heading">References</h2><div class="content"><ol class="BibliographyWrapper"><li class="Citation"><div class="CitationNumber">1.</div><div class="CitationContent" id="CR1">Volkow ND: <span class="ExternalRef"><a href="https://www.drugabuse.gov/publications/research-reports/prescription-drugs/director" rel="noopener" target="_blank"><span class="RefSource">https://www.drugabuse.gov/publications/research-reports/prescription-drugs/director</span></a></span>, 2014.<span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationNumber">2.</div><div class="CitationContent" id="CR2">Centers for Disease Control and Prevention: Vital Signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. <span class="ExternalRef"><a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm" rel="noopener" target="_blank"><span class="RefSource">www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm</span></a></span>, 2011.<span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationNumber">3.</div><div class="CitationContent" id="CR3">McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 102:63–70, 2009.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1016/j.drugalcdep.2009.01.007" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19278795" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975029" rel="noopener" target="_blank"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Subtypes%20of%20nonmedical%20prescription%20drug%20misuse&amp;author=SE.%20McCabe&amp;author=CJ.%20Boyd&amp;author=CJ.%20Teter&amp;journal=Drug%20and%20Alcohol%20Dependence&amp;volume=102&amp;pages=63-70&amp;publication_year=2009" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">4.</div><div class="CitationContent" id="CR4">McCabe SE, Teter CJ, Boyd CJ: Medical use, illicit use, and diversion of abusable prescription drugs. Journal of American College Health 54:269–278, 2006.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.3200/JACH.54.5.269-278" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16539219" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876754" rel="noopener" target="_blank"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Medical%20use%2C%20illicit%20use%2C%20and%20diversion%20of%20abusable%20prescription%20drugs&amp;author=SE.%20McCabe&amp;author=CJ.%20Teter&amp;author=CJ.%20Boyd&amp;journal=Journal%20of%20American%20College%20Health&amp;volume=54&amp;pages=269-278&amp;publication_year=2006" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">5.</div><div class="CitationContent" id="CR5">Reeves RR, Burke RS: Abuse of combinations of gabapentin and quetiapine. The Primary Care Companion for CNS Disorders 16(5):11, 2014.<span class="Occurrences"><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="https://scholar.google.com/scholar?q=Reeves%20RR%2C%20Burke%20RS%3A%20Abuse%20of%20combinations%20of%20gabapentin%20and%20quetiapine.%20The%20Primary%20Care%20Companion%20for%20CNS%20Disorders%2016%285%29%3A11%2C%202014." rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">6.</div><div class="CitationContent" id="CR6">Smith BH, Higgins C, Baldacchino A, et al.: Substance misuse of gabapentin. British Journal of General Practice 62:406–407, 2012.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.3399/bjgp12X653516" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22867659" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a class="gtm-reference" data-reference-type="PubMedCentral" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404313" rel="noopener" target="_blank"><span><span>PubMedCentral</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Substance%20misuse%20of%20gabapentin&amp;author=BH.%20Smith&amp;author=C.%20Higgins&amp;author=A.%20Baldacchino&amp;journal=British%20Journal%20of%20General%20Practice&amp;volume=62&amp;pages=406-407&amp;publication_year=2012" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">7.</div><div class="CitationContent" id="CR7">Reccoppa L, Malcolm R, Ware M: Gabapentin abuse in inmates with prior history of cocaine dependence. American Journal on Addictions 13:321–323, 2004.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1080/10550490490460300" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15370954" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Gabapentin%20abuse%20in%20inmates%20with%20prior%20history%20of%20cocaine%20dependence&amp;author=L.%20Reccoppa&amp;author=R.%20Malcolm&amp;author=M.%20Ware&amp;journal=Am%20J%20Addict.&amp;volume=13&amp;pages=321-323&amp;publication_year=2004" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">8.</div><div class="CitationContent" id="CR8">Del Paggio D: Psychotropic medication abuse in correctional facilities. <span class="ExternalRef"><a href="http://www.acbhcs.org/Psychopharmacology/2005/June2005.pdf" rel="noopener" target="_blank"><span class="RefSource">http://www.acbhcs.org/Psychopharmacology/2005/June2005.pdf</span></a></span>, 2005.<span class="Occurrences"></span></div></li><li class="Citation"><div class="CitationNumber">9.</div><div class="CitationContent" id="CR9">Reeves RR, Ladner ME: Additional evidence of the abuse potential of bupropion. Journal of clinical psychopharmacology 33:584–585, 2013.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1097/JCP.0b013e318295fe2f" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Additional%20evidence%20of%20the%20abuse%20potential%20of%20bupropion&amp;author=RR.%20Reeves&amp;author=ME.%20Ladner&amp;journal=J%20Clin%20Pyschopharmacol.&amp;volume=33&amp;pages=584-585&amp;publication_year=2013" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">10.</div><div class="CitationContent" id="CR10">Hilliard WT, Barloon L, Farley P, et al.: Bupropion diversion and misuse in the correctional facility. Journal of Correctional Health Care 19:211–217, 2013.<span class="Occurrences"><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23788587" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Bupropion%20diversion%20and%20misuse%20in%20the%20correctional%20facility&amp;author=WT.%20Hilliard&amp;author=L.%20Barloon&amp;author=P.%20Farley&amp;journal=J%20Correct%20Health%20Care.&amp;volume=19&amp;pages=211-217&amp;publication_year=2013" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">11.</div><div class="CitationContent" id="CR11">Wilens T, Zulauf C, Ryland D, et al.: Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. The American Journal on Addictions. doi:<span class="ExternalRef"> <a href="https://doi.org/10.1111/j.1521-0391.2014.12159.x" rel="noopener" target="_blank"><span class="RefSource">10.1111/j.1521-0391.2014.12159.x</span></a></span>, 2014.<span class="Occurrences"><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Prescription%20medication%20misuse%20among%20opioid%20dependent%20patients%20seeking%20inpatient%20detoxification&amp;author=T.%20Wilens&amp;author=C.%20Zulauf&amp;author=D.%20Ryland&amp;journal=Am.%20J%20Addiction.&amp;publication_year=2014&amp;doi=10.1111%2Fj.1521-0391.2014.12159.x" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">12.</div><div class="CitationContent" id="CR12">Baird CRW, Fox P, Colvin LA: Gabapentinoid abuse in order to potentiate the effect of methadone: A survey among substance misusers. European Addiction Research 20:115–118, 2014.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1159/000355268" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24192603" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Gabapentinoid%20abuse%20in%20order%20to%20potentiate%20the%20effect%20of%20methadone%3A%20A%20survey%20among%20substance%20misusers&amp;author=CRW.%20Baird&amp;author=P.%20Fox&amp;author=LA.%20Colvin&amp;journal=European%20Addiction%20Research&amp;volume=20&amp;pages=115-118&amp;publication_year=2014" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">13.</div><div class="CitationContent" id="CR13">Bozikas V, Petrikis P, Gamvrula K, et al.: Treatment of alcohol withdrawal with gabapentin. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26:197–199, 2002.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1016/S0278-5846(01)00234-2" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11853112" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Treatment%20of%20alcohol%20withdrawal%20with%20gabapentin&amp;author=V.%20Bozikas&amp;author=P.%20Petrikis&amp;author=K.%20Gamvrula&amp;journal=Progress%20in%20Neuro-Psychopharmacology%20and%20Biological%20Psychiatry&amp;volume=26&amp;pages=197-199&amp;publication_year=2002" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">14.</div><div class="CitationContent" id="CR14">Pande AC, Crockatt JG, Janney.A, et al.: Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Bipolar Disorders 2:249–255, 2000.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1034/j.1399-5618.2000.20305.x" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11249802" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Gabapentin%20in%20bipolar%20disorder%3A%20a%20placebo-controlled%20trial%20of%20adjunctive%20therapy&amp;author=AC.%20Pande&amp;author=JG.%20Crockatt&amp;author=A.%20Janney&amp;journal=Bipolar%20Disorders&amp;volume=2&amp;pages=249-255&amp;publication_year=2000" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">15.</div><div class="CitationContent" id="CR15">Pande AC, Pollack MH, Crockatt J, et al.: Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 20:467–471, 2000.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1097/00004714-200008000-00011" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Placebo-controlled%20study%20of%20gabapentin%20treatment%20of%20panic%20disorder&amp;author=AC.%20Pande&amp;author=MH.%20Pollack&amp;author=J.%20Crockatt&amp;journal=J.%20Clin%20Psychopharm.&amp;volume=20&amp;pages=467-471&amp;publication_year=2000" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">16.</div><div class="CitationContent" id="CR16">Pande AC, Davidson JRT, Jefferson, JW: Treatment of social phobia with gabapentin: A placebo-controlled study Journal of Clinical Psychopharmacology 19: 341–348, 1999.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1097/00004714-199908000-00010" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Treatment%20of%20social%20phobia%20with%20gabapentin%3A%20A%20placebo-controlled%20study&amp;author=AC.%20Pande&amp;author=JRT.%20Davidson&amp;author=JW.%20Jefferson&amp;journal=J%20Clin%20Psychopharm.&amp;volume=19&amp;pages=341-348&amp;publication_year=1999" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">17.</div><div class="CitationContent" id="CR17">Karam-Hage M, Brower KJ: Gabapentin treatment for insomnia associated with alcohol dependence. American Journal of Psychiatry. 157:151, 2000.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1176/ajp.157.1.151" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10618048" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Gabapentin%20treatment%20for%20insomnia%20associated%20with%20alcohol%20dependence&amp;author=M.%20Karam-Hage&amp;author=KJ.%20Brower&amp;journal=American%20Journal%20of%20Psychiatry&amp;volume=157&amp;pages=151&amp;publication_year=2000" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">18.</div><div class="CitationContent" id="CR18">Rocha L, Ondarza-Rovira R, Maidment NT: Gabapentin modifies extracellular opioid peptide content in amygdala: A microdialysis study. Epilepsy Research 35:13–20, 1999.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1016/S0920-1211(98)00121-1" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10232790" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Gabapentin%20modifies%20extracellular%20opioid%20peptide%20content%20in%20amygdala%3A%20a%20microdialysis%20study&amp;author=L.%20Rocha&amp;author=R.%20Ondarza-Rovira&amp;author=NT.%20Maidment&amp;journal=Epilepsy%20Research&amp;volume=35&amp;pages=13-20&amp;publication_year=1999" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li><li class="Citation"><div class="CitationNumber">19.</div><div class="CitationContent" id="CR19">Koob GF, Volkow ND: Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238, 2010.<span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a class="gtm-reference" data-reference-type="CrossRef" href="https://doi.org/10.1038/npp.2009.110" rel="noopener" target="_blank"><span><span>CrossRef</span></span></a></span><span class="Occurrence OccurrencePID"><a class="gtm-reference" data-reference-type="PubMed" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19710631" rel="noopener" target="_blank"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a class="google-scholar-link gtm-reference" data-reference-type="Google Scholar" href="http://scholar.google.com/scholar_lookup?title=Neurocircuitry%20of%20addiction&amp;author=GF.%20Koob&amp;author=ND.%20Volkow&amp;journal=Neuropsychopharmacology&amp;volume=35&amp;pages=217-238&amp;publication_year=2010" rel="noopener" target="_blank"><span><span>Google Scholar</span></span></a></span></span></div></li></ol></div></section><section class="Section1 RenderAsSection1"><h2 class="Heading" id="copyrightInformation">Copyright information</h2><div class="ArticleCopyright content"><div class="ArticleCopyright">© Springer Science+Business Media New York 2016</div></div></section></div>
</article>
<aside class="section section--collapsible" id="AboutThisContent">
<h2 class="section__heading" id="aboutcontent">About this article</h2>
<div class="section__content bibliographic-information">
<div class="crossmark" id="crossMark">
<a data-crossmark="10.1007%2Fs11126-016-9421-7" data-track="click" data-track-action="Crossmark" data-track-label="" href="https://crossmark.crossref.org/dialog/?doi=10.1007%2Fs11126-016-9421-7" rel="noopener" target="_blank" title="Verify currency and authenticity via CrossMark">
<span class="u-screenreader-only">CrossMark</span>
<svg class="CrossMark" height="81" id="crossmark-icon" width="57">
<image alt="Verify currency and authenticity via CrossMark" height="81" src="/springerlink-static/2055516157/images/png/crossmark.png" width="57" xlink:href="/springerlink-static/2055516157/images/svg/crossmark.svg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</svg>
</a>
</div>
<div class="crossmark__adjacent">
<dl class="citation-info u-highlight-target u-mb-16" id="citeas" tabindex="-1">
<dt class="test-cite-heading">
        Cite this article as:
    </dt>
<dd id="citethis-text">Bastiaens, L., Galus, J. &amp; Mazur, C. Psychiatr Q (2016) 87: 763. https://doi.org/10.1007/s11126-016-9421-7</dd>
</dl>
<ul class="bibliographic-information__list bibliographic-information__list--inline">
<li class="bibliographic-information__item">
<span class="bibliographic-information__title">First Online</span>
<span class="bibliographic-information__value u-overflow-wrap">18 February 2016</span>
</li>
<li class="bibliographic-information__item">
<span class="bibliographic-information__title">DOI</span>
<span class="bibliographic-information__value u-overflow-wrap" id="doi-url">https://doi.org/10.1007/s11126-016-9421-7</span>
</li>
<li class="bibliographic-information__item">
<span class="bibliographic-information__title">Publisher Name</span>
<span class="bibliographic-information__value" id="publisher-name">Springer US</span>
</li>
<li class="bibliographic-information__item">
<span class="bibliographic-information__title">Print ISSN</span>
<span class="bibliographic-information__value" id="print-issn">0033-2720</span>
</li>
<li class="bibliographic-information__item">
<span class="bibliographic-information__title">Online ISSN</span>
<span class="bibliographic-information__value" id="electronic-issn">1573-6709</span>
</li>
</ul>
<ul class="bibliographic-information__list">
<li class="bibliographic-information__item">
<a class="bibliographic-information__misc-links" href="//www.springer.com/journal/11126/about" id="about-journal" title="Visit Springer.com for information about this article's journal">About this journal</a>
</li>
<li class="bibliographic-information__item">
<a data-track="click" data-track-action="Reprints and Permissions" data-track-label="" href="https://s100.copyright.com/AppDispatchServlet?publisherName=SpringerNature&amp;orderBeanReset=true&amp;orderSource=SpringerLink&amp;copyright=Springer+Science%2BBusiness+Media+New+York&amp;author=Leo+Bastiaens%2C+James+Galus%2C+Cherise+Mazur&amp;issueNum=4&amp;contentID=10.1007%2Fs11126-016-9421-7&amp;endPage=767&amp;publicationDate=2016&amp;startPage=763&amp;volumeNum=87&amp;title=Abuse+of+Gabapentin+is+Associated+with+Opioid+Addiction&amp;imprint=Springer+Science%2BBusiness+Media+New+York&amp;publication=0033-2720" id="reprintsandpermissions-link" rel="noopener" target="_blank" title="Visit RightsLink for information about reusing this article">Reprints and Permissions</a>
</li>
</ul>
</div>
</div>
</aside>
<div class="section section--collapsible uptodate-recommendations gtm-recommendations">
<h2 class="uptodate-recommendations__title section__heading gtm-recommendations__title" id="uptodaterecommendations">Personalised recommendations</h2>
<div class="section__content">
<div class="uptodate-recommendations__container">
<link href="https://link.springer.com/springerlink-static/2055516157/css/recommendations.css" rel="uptodate-inline"/>
</div>
</div>
</div>
<div data-component="SpringerLink.GoogleAds" data-namespace="native" id="doubleclick-native-ad"></div>
<div aria-hidden="true" class="sticky-banner u-interface u-js-screenreader-only u-hide" data-component="SpringerLink.StickyBanner" data-namespace="hasButton">
<div class="sticky-banner__container"><span class="sticky-banner__title sticky-banner__title--short u-overflow-ellipsis" title="Abuse of Gabapentin is Associated with Opioid Addiction">Abuse of Gabapentin is Associated with Opioid Addiction</span>
<div aria-label="button with dropdown options" class="citations c-button-dropdown" data-component="SV.Dropdown" data-namespace="citationsSticky">
<button aria-controls="Dropdown-citationsSticky-dropdown" aria-expanded="false" class="c-button-dropdown__button" data-role="button-dropdown__control" id="button-Dropdown-citationsSticky-dropdown" type="button"><span class="u-overflow-ellipsis c-button-dropdown__button-title">
<span>Cite</span>
<span class="hide-text-small">article</span>
</span><span class="c-button-dropdown__icon"></span></button>
<div aria-hidden="true" aria-label="dropdown" class="u-composite-layer c-button-dropdown__container" id="Dropdown-citationsSticky-dropdown"><ul class="citations__content" data-role="button-dropdown__content">
<li>
<a data-track="click" data-track-action="Cite as link" data-track-label="Cite dropdown" href="https://link.springer.com/#citeas" tabindex="-1">How to cite?</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="RIS" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=refman&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .RIS file">
<span class="citations__extension" data-gtmlabel="RIS">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .RIS
                </span>
<span class="citations__types">
<span>
                            Papers
                        </span>
<span>
                            Reference Manager
                        </span>
<span>
                            RefWorks
                        </span>
<span>
                            Zotero
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="ENW" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=endnote&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .ENW file">
<span class="citations__extension" data-gtmlabel="ENW">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .ENW
                </span>
<span class="citations__types">
<span>
                            EndNote
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="BIB" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=bibtex&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .BIB file">
<span class="citations__extension" data-gtmlabel="BIB">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .BIB
                </span>
<span class="citations__types">
<span>
                            BibTeX
                        </span>
<span>
                            JabRef
                        </span>
<span>
                            Mendeley
                        </span>
</span>
</a>
</li>
</ul></div>
</div>
<div>
<a class="c-button share-this test-shareby-sharelink-link" data-test="shareable-link" data-track="click" data-track-action="Share via" data-track-label="ShareLink" href="https://link.springer.com/sharelink/10.1007/s11126-016-9421-7" rel="noopener" target="_blank">
<span>Share</span>
<span class="hide-text-small">article</span>
</a>
</div>
<div>
<a class="c-button c-button--blue c-button__icon-right" data-track="click" data-track-action="Pdf download" data-track-label="" href="https://link.springer.com/content/pdf/10.1007%2Fs11126-016-9421-7.pdf" rel="noopener" target="_blank" title="Download this article in PDF format">
<svg height="24" version="1.1" viewbox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd" stroke="none" stroke-width="1"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"></path></g></g></g></svg>
<span class="hide-text-small">Download</span>
<span>PDF</span>
</a>
</div>
</div>
</div>
</div>
<aside class="main-sidebar-right u-interface">
<div data-role="sticky-wrapper">
<div class="main-sidebar-right__content u-composite-layer" data-component="SpringerLink.StickySidebar">
<div class="article-actions" id="article-actions">
<h2 aria-hidden="true" class="u-screenreader-only">Actions</h2>
<div class="u-js-hide u-js-show-two-col">
<div class="download-article test-pdf-link">
<div>
<a class="c-button c-button--blue c-button__icon-right" data-track="click" data-track-action="Pdf download" data-track-label="" href="https://link.springer.com/content/pdf/10.1007%2Fs11126-016-9421-7.pdf" rel="noopener" target="_blank" title="Download this article in PDF format">
<svg height="24" version="1.1" viewbox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd" stroke="none" stroke-width="1"><g fill="#fff"><g transform="translate(12.000000, 5.000000)"><path d="M7 7.3L7 1C7 0.4 6.6 0 6 0 5.4 0 5 0.4 5 1L5 7.3 3.5 5.7C3.1 5.3 2.5 5.3 2.1 5.7L2.1 5.7C1.7 6.1 1.7 6.7 2.1 7.1L5.3 10.3C5.7 10.7 6.3 10.7 6.7 10.3L9.9 7.1C10.3 6.7 10.3 6.1 9.9 5.7L9.9 5.7C9.5 5.3 8.9 5.3 8.5 5.7L7 7.3 7 7.3ZM0 13C0 12.4 0.5 12 1 12L11 12C11.6 12 12 12.4 12 13 12 13.6 11.5 14 11 14L1 14C0.4 14 0 13.6 0 13L0 13Z"></path></g></g></g></svg>
<span class="hide-text-small">Download</span>
<span>PDF</span>
</a>
</div>
</div>
<div aria-label="button with dropdown options" class="citations c-button-dropdown" data-component="SV.Dropdown" data-namespace="citations">
<button aria-controls="Dropdown-citations-dropdown" aria-expanded="false" class="c-button-dropdown__button" data-role="button-dropdown__control" id="button-Dropdown-citations-dropdown" type="button"><span class="u-overflow-ellipsis c-button-dropdown__button-title">
<span>Cite</span>
<span class="hide-text-small">article</span>
</span><span class="c-button-dropdown__icon"></span></button>
<div aria-hidden="true" aria-label="dropdown" class="u-composite-layer c-button-dropdown__container" id="Dropdown-citations-dropdown"><ul class="citations__content" data-role="button-dropdown__content">
<li>
<a data-track="click" data-track-action="Cite as link" data-track-label="Cite dropdown" href="https://link.springer.com/#citeas" tabindex="-1">How to cite?</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="RIS" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=refman&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .RIS file">
<span class="citations__extension" data-gtmlabel="RIS">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .RIS
                </span>
<span class="citations__types">
<span>
                            Papers
                        </span>
<span>
                            Reference Manager
                        </span>
<span>
                            RefWorks
                        </span>
<span>
                            Zotero
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="ENW" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=endnote&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .ENW file">
<span class="citations__extension" data-gtmlabel="ENW">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .ENW
                </span>
<span class="citations__types">
<span>
                            EndNote
                        </span>
</span>
</a>
</li>
<li>
<a data-track="click" data-track-action="Export citation" data-track-label="BIB" href="//citation-needed.springer.com/v2/references/10.1007/s11126-016-9421-7?format=bibtex&amp;flavour=citation" tabindex="-1" title="Download this article's citation as a .BIB file">
<span class="citations__extension" data-gtmlabel="BIB">
<svg class="u-vertical-align-absolute" height="14" viewbox="0 0 12 14" width="12" xmlns="http://www.w3.org/2000/svg"><path d="M7 7.269v-6.271c0-.551-.448-.998-1-.998-.556 0-1 .447-1 .998v6.271l-1.5-1.547c-.375-.387-1.01-.397-1.401-.006l.016-.016c-.397.397-.391 1.025-.001 1.416l3.178 3.178c.392.392 1.024.391 1.415 0l3.178-3.178c.392-.392.391-1.025-.001-1.416l.016.016c-.397-.397-1.018-.388-1.401.006l-1.5 1.547zm-7 5.731c0-.552.456-1 1.002-1h9.995c.554 0 1.002.444 1.002 1 0 .552-.456 1-1.002 1h-9.995c-.554 0-1.002-.444-1.002-1z" fill="#004aa7"></path></svg>
                    .BIB
                </span>
<span class="citations__types">
<span>
                            BibTeX
                        </span>
<span>
                            JabRef
                        </span>
<span>
                            Mendeley
                        </span>
</span>
</a>
</li>
</ul></div>
</div>
<div>
<a class="c-button share-this test-shareby-sharelink-link" data-test="shareable-link" data-track="click" data-track-action="Share via" data-track-label="ShareLink" href="https://link.springer.com/sharelink/10.1007/s11126-016-9421-7" rel="noopener" target="_blank">
<span>Share</span>
<span class="hide-text-small">article</span>
</a>
</div>
</div>
</div>
<nav aria-label="article contents" class="toc">
<h2 aria-hidden="true" class="u-screenreader-only">Table of contents</h2>
<ul class="article-contents" id="article-contents" tabindex="-1">
<li>
<a href="https://link.springer.com/#enumeration" title="Article"><span class="u-overflow-ellipsis">Article</span></a>
</li>
<li>
<a href="https://link.springer.com/#Abs1" title="Abstract"><span class="u-overflow-ellipsis">Abstract</span></a>
</li>
<li>
<a href="https://link.springer.com/#Sec1" title="Introduction"><span class="u-overflow-ellipsis">Introduction</span></a>
</li>
<li>
<a href="https://link.springer.com/#Sec2" title="Method"><span class="u-overflow-ellipsis">Method</span></a>
</li>
<li>
<a href="https://link.springer.com/#Sec3" title="Results"><span class="u-overflow-ellipsis">Results</span></a>
</li>
<li>
<a href="https://link.springer.com/#Sec4" title="Discussion"><span class="u-overflow-ellipsis">Discussion</span></a>
</li>
<li>
<a href="https://link.springer.com/#Notes" title="Notes"><span class="u-overflow-ellipsis">Notes</span></a>
</li>
<li>
<a href="https://link.springer.com/#Bib1" title="References"><span class="u-overflow-ellipsis">References</span></a>
</li>
<li>
<a href="https://link.springer.com/#copyrightInformation" title="Copyright information"><span class="u-overflow-ellipsis">Copyright information</span></a>
</li>
<li>
<a href="https://link.springer.com/#aboutcontent" title="About this article"><span class="u-overflow-ellipsis">About this article</span></a>
</li>
</ul>
</nav>
</div>
<div class="skyscraper-ad u-hide" data-component="SpringerLink.GoogleAds" data-namespace="skyscraper">
<div class="skyscraper-ad__wrapper">
<p class="skyscraper-ad__label">Advertisement</p>
<button class="skyscraper-ad__hide" data-track="click" data-track-action="Hide advertisement" data-track-label="" title="Hide this advertisement">Hide</button>
<div class="skyscraper-ad__ad" id="doubleclick-ad"></div>
</div>
</div>
</div>
</aside>
</div>
</main>
<footer class="footer u-interface">
<div class="footer__aside-wrapper">
<div class="footer__content">
<div class="footer__aside">
<p class="footer__strapline">Over 10 million scientific documents at your fingertips</p>
<div aria-label="button with dropdown options" class="footer__edition c-button-dropdown c-button-dropdown--ghost" data-component="SV.EditionSwitcher">
<button aria-controls="EditionSwitcher-1181111949-dropdown" aria-expanded="false" class="c-button-dropdown__button" data-role="button-dropdown__control" id="button-EditionSwitcher-1181111949-dropdown" title="Switch between Academic &amp; Corporate Edition" type="button"><span class="u-overflow-ellipsis c-button-dropdown__button-title">Academic Edition</span><span class="c-button-dropdown__icon"></span></button>
<div aria-hidden="true" aria-label="dropdown" class="u-composite-layer c-button-dropdown__container" id="EditionSwitcher-1181111949-dropdown"><ul data-role="button-dropdown__content">
<li class="selected"><a href="https://link.springer.com/siteEdition/link?previousUrl=/article/10.1007/s11126-016-9421-7&amp;id=siteedition-academic-link" id="siteedition-academic-link">Academic Edition</a></li>
<li><a href="https://link.springer.com/siteEdition/rd?previousUrl=/article/10.1007/s11126-016-9421-7&amp;id=siteedition-corporate-link" id="siteedition-corporate-link" tabindex="-1">Corporate Edition</a></li>
</ul></div>
</div>
</div>
</div>
</div>
<div class="footer__content">
<ul class="footer__nav">
<li>
<a href="https://link.springer.com/">Home</a>
</li>
<li>
<a href="https://link.springer.com/impressum">Impressum</a>
</li>
<li>
<a href="https://link.springer.com/termsandconditions">Legal information</a>
</li>
<li>
<a href="https://link.springer.com/privacystatement">Privacy statement</a>
</li>
<li>
<a href="https://link.springer.com/cookiepolicy">How we use cookies</a>
</li>
<li>
<a href="https://link.springer.com/accessibility">Accessibility</a>
</li>
<li>
<a href="https://link.springer.com/contactus" id="contactus-footer-link">Contact us</a>
</li>
</ul>
<a class="parent-logo" href="//www.springernature.com" rel="noopener" target="_blank" title="Go to Springer Nature">
<span class="u-screenreader-only">Springer Nature</span>
<svg aria-hidden="true" focusable="false" height="12" width="125">
<image height="12" src="/springerlink-static/2055516157/images/png/springernature.png" width="125" xlink:href="/springerlink-static/2055516157/images/svg/springernature.svg" xmlns:xlink="http://www.w3.org/1999/xlink">
</image>
</svg>
</a>
<p class="footer__copyright">© 2019 Springer Nature Switzerland AG. Part of <a href="//www.springernature.com" rel="noopener" target="_blank">Springer Nature</a>.</p>
<p class="footer__user-access-info">
<span>Not logged in</span>
<span>National University of Ireland Galway, James Hardiman Lib (3000081220) - IRIS - LNCS (3000178775) - IReL Consortium c/o The Library Maynooth University (3000215760) - 1255 IRIS Ireland (3000240761)</span>
<span>140.203.154.11</span>
</p>
</div>
</footer>
</div>
<script type="text/javascript">
    (function() {
        var linkEl = document.querySelector('.js-ctm');
        var scriptsList = [];
        var polyfillFeatures = '';

        window.SpringerLink = window.SpringerLink || {};
        window.SpringerLink.staticLocation = '/springerlink-static/2055516157';
        window.eventTrackerInstance = null;

        if (window.matchMedia && window.matchMedia(linkEl.media).matches) {
            (function(h){h.className = h.className.replace('no-js', 'js')})(document.documentElement);

            polyfillFeatures = 'default,fetch,Promise,Object.setPrototypeOf,Object.entries,Number.isInteger,MutationObserver,startsWith,Array.prototype.includes,Array.from,IntersectionObserver';

            scriptsList = [
                'https://cdn.polyfill.io/v2/polyfill.min.js?features=' + polyfillFeatures + '&flags=gated',
                window.SpringerLink.staticLocation + '/js/main.js'
            ];

            scriptsList.forEach(function(script) {
                var tag = document.createElement('script');
                tag.async = false;
                tag.src = script;

                document.body.appendChild(tag);
            });
        }
    })();
</script><script src="https://cdn.polyfill.io/v2/polyfill.min.js?features=default,fetch,Promise,Object.setPrototypeOf,Object.entries,Number.isInteger,MutationObserver,startsWith,Array.prototype.includes,Array.from,IntersectionObserver&amp;flags=gated"></script><script src="https://link.springer.com/springerlink-static/2055516157/js/main.js"></script>
<script id="googletag-push" type="text/javascript">
        
            var adSlot = '270604982/springerlink/11126/article';
        

        var definedSlots = [
                {slot: [728, 90], containerName: 'doubleclick-leaderboard-ad'},
                {slot: [160, 600], containerName: 'doubleclick-ad'},
            {slot: [2, 2], containerName: 'doubleclick-native-ad'}
        ];
    </script>
<span class="u-hide" id="chat-widget"></span>
<noscript>
<img alt="" aria-hidden="true" height="1" role="presentation" src="https://ssl-springer.met.vgwort.de/na/pw-vgzm.415900-10.1007-s11126-016-9421-7" width="1"/>
</noscript>
<img alt="" data-test="tracking-pixel" height="1" src="https://link.springer.com/track/controlled/article/granted/10.1007/s11126-016-9421-7?bps=%5B%5B%223000081220%22%2C%22Institution%22%2C%22National+University+of+Ireland+Galway%2C+James+Hardiman+Lib%22%5D%2C%5B%223000178775%22%2C%22Consortium%22%2C%22IRIS+-+LNCS%22%5D%2C%5B%223000215760%22%2C%22Consortium%22%2C%22IReL+Consortium+c%2Fo+The+Library+Maynooth+University%22%5D%2C%5B%223000240761%22%2C%22Consortium%22%2C%221255+IRIS+Ireland%22%5D%5D" width="1"/>
<button aria-hidden="true" class="js-focus-catcher u-screenreader-only" href="javascript:;" tabindex="-1" title="focus catcher"></button><div class="modern" id="optanon"><div id="optanon-popup-bg"></div><div aria-modal="true" id="optanon-popup-wrapper" lang="en-GB" role="dialog" tabindex="-1"><div id="optanon-popup-top"><a class="optanon-close-link optanon-close optanon-close-ui" href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Preferences Close Button');" title="Close Preference Centre"><div id="optanon-close" style="background: url(https://optanon.blob.core.windows.net/skins/default_flat_bottom_two_button_white/v2/images/optanon-pop-up-close.png);width:34px;height:34px;"></div></a></div><div id="optanon-popup-body"><div id="optanon-popup-body-left"><div id="optanon-popup-body-left-shading"></div><div id="optanon-branding-top-logo" style="background-image: url(https://optanon.blob.core.windows.net/logos/5138/5138:link.springer.com/springer.png) !important;"></div><ul id="optanon-menu"><li class="menu-item-on menu-item-about" title="Your Privacy"><p><a href="https://link.springer.com/#">Your Privacy</a></p></li><li class="menu-item-necessary menu-item-on" title="Strictly Necessary Cookies"><p><a href="https://link.springer.com/#">Strictly Necessary Cookies</a></p></li><li class="menu-item-on menu-item-performance" title="Performance Cookies"><p><a href="https://link.springer.com/#">Performance Cookies</a></p></li><li class="menu-item-on menu-item-functional" title="Functional Cookies"><p><a href="https://link.springer.com/#">Functional Cookies</a></p></li><li class="menu-item-on menu-item-advertising" title="Targeting Cookies"><p><a href="https://link.springer.com/#">Targeting Cookies</a></p></li><li class="menu-item-moreinfo menu-item-off" title="More Information"><p><a href="https://link.springer.com/cookiepolicy" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Preferences Cookie Policy');" target="_blank">More Information</a></p></li></ul></div><div id="optanon-popup-body-right"><h2 aria-label="true">Privacy Preference Centre</h2><h3></h3><div id="optanon-popup-more-info-bar"><div class="optanon-status"><div class="optanon-status-editable"><form><fieldset><p><input checked="" class="optanon-status-checkbox" id="chkMain" type="checkbox" value="check"/><label for="chkMain">Active</label></p></fieldset></form></div><div class="optanon-status-always-active optanon-status-on"><p>Always Active</p></div></div></div><div id="optanon-main-info-text"></div></div><div class="optanon-bottom-spacer"></div></div><div id="optanon-popup-bottom"> <a href="https://onetrust.com/poweredbyonetrust" target="_blank"><div id="optanon-popup-bottom-logo" style="background: url(https://optanon.blob.core.windows.net/skins/default_flat_bottom_two_button_white/v2/images/cookie-collective-top-bottom.png);width:155px;height:35px;" title="powered by OneTrust"></div></a><div class="optanon-button-wrapper optanon-save-settings-button optanon-close optanon-close-consent"><div class="optanon-white-button-left"></div><div class="optanon-white-button-middle"><a href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Preferences Save Settings');">Save Settings</a></div><div class="optanon-white-button-right"></div></div><div class="optanon-button-wrapper optanon-allow-all-button optanon-allow-all" style="display: none;"><div class="optanon-white-button-left"></div><div class="optanon-white-button-middle"><a href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Preferences Allow All');">Allow All</a></div><div class="optanon-white-button-right"></div></div></div></div></div><div class="optanon-alert-box-wrapper" style="bottom: -137.905px;"><div class="optanon-alert-box-bottom-top"><div class="optanon-alert-box-corner-close"><a class="optanon-alert-box-close" href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Banner Close Button');" title="Close Banner"></a></div></div><div class="optanon-alert-box-bg"><div class="optanon-alert-box-logo"> </div><div class="optanon-alert-box-body"><p>We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners in accordance with our <a href="https://link.springer.com/privacystatement">Privacy Statement</a>. You can manage your preferences in Manage Cookies.</p></div><div class="optanon-clearfix"></div><div class="optanon-alert-box-button-container"><div class="optanon-alert-box-button optanon-button-close"><div class="optanon-alert-box-button-middle"><a class="optanon-alert-box-close" href="https://link.springer.com/#">Close</a></div></div><div class="optanon-alert-box-button optanon-button-allow"><div class="optanon-alert-box-button-middle"><a class="optanon-allow-all" href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Banner Accept Cookies');">OK</a></div></div><div class="optanon-alert-box-button optanon-button-more"><div class="optanon-alert-box-button-middle"><a class="optanon-toggle-display" href="https://link.springer.com/#" onclick="Optanon.TriggerGoogleAnalyticsEvent('OneTrust Cookie Consent', 'Banner Open Preferences');">Manage Cookies</a></div></div></div><div class="optanon-clearfix optanon-alert-box-bottom-padding"></div></div></div><script id="eventtracker-init" type="text/javascript">var eventTrackerBaseUrl="https:\/\/event-tracker.springernature.com",eventTrackerInstance=null;if("undefined"!==eventTrackerBaseUrl){var script=document.createElement("script");script.src=eventTrackerBaseUrl+"/dist/eventTracker.js";script.type="text/javascript";script.async=!0;script.defer=!0;script.onload=function(){eventTrackerInstance=new EventTracker({baseUrl:eventTrackerBaseUrl,platform:google_tag_manager["GTM-WCF9Z9"].macro(13)});dataLayer.push({event:"eventTrackerActive"})};document.body.appendChild(script)};</script><script async="" defer="" src="https://event-tracker.springernature.com/dist/eventTracker.js" type="text/javascript"></script><div style="display: none; visibility: hidden;"><script id="gpt-control-script" src="https://www.googletagservices.com/tag/js/gpt.js"></script></div><script id="ga-data-track-event-listeners" type="text/javascript">var setupHandler=google_tag_manager["GTM-WCF9Z9"].macro(41);setupHandler("click");setupHandler("submit");</script><script id="gtm-recommendations-script" src="//recommended.springernature.com/latest/generated/entry-point.js" type="text/javascript"></script></body></html>